| abstract |
Electrical devices (e.g., cardiac rhythm management and neurostirnulation devices) for contact with tissue are used in combination with an anti-scarring agent (e.g., a cell cycle inhibitor) in order to inhibit scarring that may otherwise occur when the devices are implanted within an animal. |